Luca Quagliata
Private Equity Investor chez Xgen Venture Sgr SpA
Profil
Dr Luca Quagliata joined XGEN as Venture Partner in 2023.
Luca is VP and Global Head of Medical Affairs for the Genetic Science Group at Thermo Fisher Scientific.
Before joining Thermo Fisher, Luca worked as Senior Director and Team Leader of the Molecular Diagnostics Division at the Institute of Pathology, University Hospital Basel, Switzerland.
Luca is trained in Medical Biotechnology (Naples, Italy), holds a Ph.D.
in Vascular Medicine (Heidelberg, Germany), a Certificate of Achievement (COA) in Genetics (Harvard, Boston), was a visiting fellow at the NCI-NIH (Bethesda, USA), and is a Board-Certified Specialist in Medical Affairs (BCMAS).
Postes actifs de Luca Quagliata
Sociétés | Poste | Début |
---|---|---|
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Private Equity Investor | 01/01/2023 |
Formation de Luca Quagliata
Heidelberg University (Ohio) | Doctorate Degree |
Università degli Studi di Napoli Federico II | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
Xgen Venture Sgr SpA
Xgen Venture Sgr SpA Investment ManagersFinance Xgen Venture Sgr SpA (XGEN Venture) is a venture capital firm founded in 2021 by Federica Draghi, Paolo Fundarò and Daniele Scarinci. The firm is headquartered in Milan, Italy. | Finance |